Cart
sales@molnova.com
SP420
CAS No. 911714-45-9
SP420( SP 420 | SP-420 )
Catalog No. M20105 CAS No. 911714-45-9
SP-420 is a novel orally active iron chelator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 68 | In Stock |
|
| 5MG | 62 | In Stock |
|
| 10MG | 113 | In Stock |
|
| 25MG | 254 | In Stock |
|
| 50MG | 443 | In Stock |
|
| 100MG | 703 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSP420
-
NoteResearch use only, not for human use.
-
Brief DescriptionSP-420 is a novel orally active iron chelator.
-
DescriptionSP-420 is a novel orally active iron chelator.
-
In Vitro——
-
In Vivo——
-
SynonymsSP 420 | SP-420
-
PathwayOthers
-
TargetOther Targets
-
Recptoriron chelator
-
Research AreaOthers
-
IndicationIron overload
Chemical Information
-
CAS Number911714-45-9
-
Formula Weight355.41
-
Molecular FormulaC16H21NO6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 35 mg/mL (98.48 mM)
-
SMILESCOCCOCCOc1ccc(C2=N[C@](C)(CS2)C(O)=O)c(O)c1
-
Chemical Name(4S)-45-Dihydro-2-[2-hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl]-4-methyl-4-thiazolecarboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bergeron RJ et al. Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles. J Med Chem. 2012 Aug 23;55(16):7090-103.
molnova catalog
related products
-
Ginsenoside Rg5
Ginsenoside Rg5 could be a beneficial agent for the treatment of Alzheimer's disease.
-
GRGDSP acetate(91037...
GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.
-
IGS-1.76
IGS-1.76 shows a significantly increased affinity for hNCS-1 and is able to modulate the hNCS-1/Ric8a interaction efficiently.IGS-1.76 efficiently inhibits the human NCS-1/Ric8a complex.IGS-1.76, which efficiently inhibits the human NCS-1/Ric8a complex with improved binding potency.?
